Science Explorer Back to mapMap

Most cited papers from Hokko Memorial Hospital

What are the most cited papers from Hokko Memorial Hospital?

The most cited paper from Hokko Memorial Hospital is "High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD)" (Isao Taguchi et al., 2018), with 246 citations. Next come "Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75)" (227) and "Drug-Induced Long-QT Syndrome Associated With a Subclinical SCN5A Mutation" (178).

Showing 50 of 60 papers. Every paper with more than 17 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD) Isao Taguchi et al. · Circulation Open access 7 May 2018 246
2 Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75) Yasuyoshi Ouchi et al. · Circulation Open access 22 Aug 2019 227
3 Drug-Induced Long-QT Syndrome Associated With a Subclinical SCN5A Mutation Naomasa Makita, Minoru Horie, Takeshi Nakamura et al. · Circulation Open access 3 Sep 2002 178
4 Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain Yuko Kawai, Eriko Tsukamoto, Yoichi Nozaki et al. · Journal of the American College of Cardiology Open access Dec 2001 136
5 Differential metabolic effects of distinct statins Kwang Kon Koh, Ichiro Sakuma, Michael J. Quon · Atherosclerosis 3 Nov 2010 130
6 Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease Kyoung Im Cho, Ichiro Sakuma, Il Suk Sohn et al. · Atherosclerosis 25 Aug 2018 126
7 Target International Normalized Ratio Values for Preventing Thromboembolic and Hemorrhagic Events in Japanese Patients With Non-Valvular Atrial Fibrillation Hiroshi Inoue et al. · Circulation Journal Open access 2013 123
8 Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II Study) Takeshi Yamashita et al. · EP Europace Open access 10 Dec 2010 117
9 Antiatherosclerotic and Anti-Insulin Resistance Effects of Adiponectin: Basic and Clinical Studies Seung Hwan Han, Ichiro Sakuma, Eak Kyun Shin et al. · Progress in Cardiovascular Diseases Sep 2009 116
10 α9 Integrin and Its Ligands Constitute Critical Joint Microenvironments for Development of Autoimmune Arthritis Masashi Kanayama, Daisuke Kurotaki, Junko O. Morimoto et al. · The Journal of Immunology Jun 2009 91
11 How to control residual cardiovascular risk despite statin treatment: Focusing on HDL–cholesterol Soo Lim, Yae Min Park, Ichiro Sakuma et al. · International Journal of Cardiology 12 Apr 2012 66
12 Impact of Gender on the Prognosis of Patients With Nonvalvular Atrial Fibrillation Hiroshi Inoue et al. · The American Journal of Cardiology 25 Dec 2013 61
13 Significant differential effects of omega-3 fatty acids and fenofibrate in patients with hypertriglyceridemia Kwang Kon Koh, Michael J. Quon, Kwen-Chul Shin et al. · Atherosclerosis 20 Nov 2011 61
14 Hypertriglyceridemia and Cardiovascular Diseases: Revisited Seung Hwan Han, Stephen James Nicholls, Ichiro Sakuma et al. · Korean Circulation Journal Open access 2016 59
15 Omega-3 fatty acid therapy dose-dependently and significantly decreased triglycerides and improved flow-mediated dilation, however, did not significantly improve insulin sensitivity in patients with hypertriglyceridemia Pyung Chun Oh, Kwang Kon Koh, Ichiro Sakuma et al. · International Journal of Cardiology 8 Aug 2014 54
16 Differential metabolic effects of rosuvastatin and pravastatin in hypercholesterolemic patients Kwang Kon Koh, Michael J. Quon, Ichiro Sakuma et al. · International Journal of Cardiology 26 Dec 2011 53
17 Effect of Intensive Lipid-Lowering Therapy With Rosuvastatin on Progression of Carotid Intima-Media Thickness in Japanese Patients Ryuji Nohara, Hiroyuki Daida, Mitsumasa Hata et al. · Circulation Journal Open access 16 Nov 2011 51
18 The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation Hiroaki Shimokawa et al. · International Journal of Cardiology Open access 3 Feb 2018 48
19 Use of 123 I-BMIPP single-photon emission tomography to estimate areas at risk following successful revascularization in patients with acute myocardial infarction Yuko Kawai, Eriko Tsukamoto, Yoichi Nozaki et al. · European Journal of Nuclear Medicine and Molecular Imaging 29 Sep 1998 42
20 Efficacy and safety of sitagliptin treatment in older adults with moderately controlled type 2 diabetes: the STREAM study Mototsugu Nagao et al. · Scientific Reports Open access 4 Jan 2023 41
21 Statins and Renin-Angiotensin System Inhibitor Combination Treatment to Prevent Cardiovascular Disease Hae‐Young Lee, Ichiro Sakuma, Sang‐Hyun Ihm et al. · Circulation Journal Open access 2014 40
22 Impact of Weekly Teriparatide on the Bone and Mineral Metabolism in Hemodialysis Patients With Relatively Low Serum Parathyroid Hormone: A Pilot Study Junya Yamamoto, Daigo Nakazawa, Saori Nishio et al. · Therapeutic Apheresis and Dialysis 18 Jun 2019 39
23 Coexistence of Visceral Fat and Multiple Risk Factor Accumulations is Strongly Associated with Coronary Artery Disease in Japanese (The VACATION-J Study) Aki Hiuge-Shimizu, Ken Kishida, Tohru Funahashi et al. · Journal of Atherosclerosis and Thrombosis Open access 2012 39
24 Long-term Outcomes of Anterior Spinal Fusion for Treating Thoracic Adolescent Idiopathic Scoliosis Curves Hideki Sudo, Manabu Ito, Kiyoshi Kaneda et al. · Spine 20 Nov 2012 38
25 Ipragliflozin and sitagliptin differentially affect lipid and apolipoprotein profiles in type 2 diabetes: the SUCRE study Mototsugu Nagao, Junichi Sasaki, Kyoko Tanimura‐Inagaki et al. · Cardiovascular Diabetology Open access 8 Feb 2024 37
26 Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes Mellitus Masato Furuhashi, Ichiro Sakuma, Takeshi Morimoto et al. · Frontiers in Endocrinology Open access 23 Sep 2020 36
27 Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy Masato Furuhashi, Ichiro Sakuma, Takeshi Morimoto et al. · Cardiovascular Diabetology Open access 15 Jun 2020 35
28 Effect of Long-Term Intensive Lipid-Lowering Therapy With Rosuvastatin on Progression of Carotid Intima-Media Thickness Ryuji Nohara, Hiroyuki Daida, Mitsumasa Hata et al. · Circulation Journal Open access 2013 35
29 Potentially important considerations in choosing specific statin treatments to reduce overall morbidity and mortality Soo Lim, Ichiro Sakuma, Michael J. Quon et al. · International Journal of Cardiology 16 Nov 2012 35
30 Vascular and metabolic effects of ezetimibe combined with simvastatin in patients with hypercholesterolemia Kwang Kon Koh, Pyung Chun Oh, Ichiro Sakuma et al. · International Journal of Cardiology 11 Jul 2015 34
31 Effects of fenofibrate therapy on circulating adipocytokines in patients with primary hypertriglyceridemia Kwang Kon Koh, Michael J. Quon, Soo Lim et al. · Atherosclerosis 30 Oct 2010 33
32 Important factors in left atrial posterior wall isolation using 28‐mm cryoballoon ablation for persistent atrial fibrillation—Block line or isolation area? Tadafumi Nanbu, Akihiko Yotsukura, George Suzuki et al. · Journal of Cardiovascular Electrophysiology 20 Nov 2019 32
33 Frequency and time course of reocclusion and restenosis in coronary artery occlusions after balloon angioplasty versus wiktor stent implantation: results from the Mayo-Japan Investigation for Chronic Total Occlusion (MAJIC) Trial Hideo Tamai, Peter B. Berger, Etsuo Tsuchikane et al. · American Heart Journal Mar 2004 32
34 Controversies in the 2017 ACC/AHA Hypertension Guidelines: Who Can Be Eligible for Treatments Under the New Guidelines? ― An Asian Perspective ― Sang‐Hyun Ihm, George L. Bakris, Ichiro Sakuma et al. · Circulation Journal Open access 28 Dec 2018 31
35 How to balance cardiorenometabolic benefits and risks of statins Soo Lim, Pyung Chun Oh, Ichiro Sakuma et al. · Atherosclerosis 16 Jun 2014 31
36 Small Dense Low-Density Lipoprotein Cholesterol and Cardiovascular Risk in Statin-Treated Patients with Coronary Artery Disease Junnichi Ishii et al. · Journal of Atherosclerosis and Thrombosis Open access 8 Dec 2021 28
37 Combination Pravastatin and Valsartan Treatment Has Additive Beneficial Effects to Simultaneously Improve Both Metabolic and Cardiovascular Phenotypes Beyond That of Monotherapy With Either Drug in Patients With Primary Hypercholesterolemia Kwang Kon Koh, Soo Lim, Hanul Choi et al. · Diabetes Open access 18 Jul 2013 28
38 Investigation of Gastric and Duodenal Mucosal Defects Caused by Low-dose Aspirin in Patients With Ischemic Heart Disease Hiroaki Nema, Mototsugu Kato, Takehiko Katsurada et al. · Journal of Clinical Gastroenterology 16 Jan 2009 27
39 Intensive Lipid-Lowering Therapy for Slowing Progression as Well as Inducing Regression of Atherosclerosis in Japanese Patients Tsutomu Yamazaki, Ryuji Nohara, Hiroyuki Daida et al. · International Heart Journal Open access 2013 27
40 Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events Masashi Sakuma, Satoshi Iimuro, Tomohiro Shinozaki et al. · BMC Medicine Open access 14 Nov 2022 25
41 Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events Kwang Kon Koh, Ichiro Sakuma, Kazunori Shimada et al. · Korean Circulation Journal Open access 12 Dec 2016 25
42 Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysis Ichiro Sakuma, Shinichiro Uchiyama, Hirotsugu Atarashi et al. · Heart and Vessels Open access 24 May 2019 24
43 Caveats to aggressive lowering of lipids by specific statins Kwang Kon Koh, Soo Lim, Ichiro Sakuma et al. · International Journal of Cardiology 16 Oct 2011 24
44 Endoscopic survey of low‐dose‐aspirin‐induced gastroduodenal mucosal injuries in patients with ischemic heart disease Hiroaki Nema, Mototsugu Kato, Takehiko Katsurada et al. · Journal of Gastroenterology and Hepatology Dec 2008 24
45 Role of Left Ventricular Regional Diastolic Abnormalities for Global Diastolic Dysfunction in Patients with Hypertrophic Cardiomyopathy Kazutomo Goto, Taisei Mikami, Hisao Onozuka et al. · Journal of the American Society of Echocardiography Jul 2006 24
46 Differential Metabolic Actions of Specific Statins: Clinical and Therapeutic Considerations Soo Lim, Ichiro Sakuma, Michael J. Quon et al. · Antioxidants and Redox Signaling Open access 8 Aug 2013 24
47 Best Treatment Strategies With Statins to Maximize the Cardiometabolic Benefits Kyoung Im Cho, Ichiro Sakuma, Il Suk Sohn et al. · Circulation Journal Open access 2018 23
48 Does Treatment of Impaired Glucose Tolerance Improve Cardiovascular Outcomes in Patients with Previous Myocardial Infarction? ABC investigators et al. · Cardiovascular Drugs and Therapy Aug 2017 22
49 Diagnostic Value of 123I-Betamethyl-p-Iodophenyl-Pentadecanoic Acid (BMIPP) Single Photon Emission Computed Tomography (SPECT) in Patients With Chest Pain-Comparison With Rest-Stress 99mTc-Tetrofosmin SPECT and Coronary Angiography- Yuko Kawai, Koichi Morita, Yoichi Nozaki et al. · Circulation Journal Open access 2004 22
50 Comparison of 5-Year Outcomes in Patients With and Without Unprotected Left Main Coronary Artery Disease After Treatment With Sirolimus-Eluting Stents Mamoru Toyofuku, Takeshi Kimura, Takeshi Morimoto et al. · JACC: Cardiovascular Interventions Open access Jul 2013 22

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.